INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 100 filers reported holding INARI MED INC in Q3 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,396,287 | -35.1% | 51,931 | -42.3% | 0.05% | -27.8% |
| Q2 2023 | $5,236,612 | -6.1% | 90,069 | -0.3% | 0.07% | -21.7% |
| Q1 2023 | $5,576,110 | +32.1% | 90,316 | +36.0% | 0.09% | +16.5% |
| Q4 2022 | $4,220,638 | -36.9% | 66,404 | -27.9% | 0.08% | -32.5% |
| Q3 2022 | $6,694,000 | +9.6% | 92,154 | +2.6% | 0.12% | +7.3% |
| Q2 2022 | $6,105,000 | +111.9% | 89,794 | +182.5% | 0.11% | +303.7% |
| Q1 2022 | $2,881,000 | -71.7% | 31,789 | -71.5% | 0.03% | -53.4% |
| Q4 2021 | $10,179,000 | -42.1% | 111,524 | -48.6% | 0.06% | -36.3% |
| Q3 2021 | $17,590,000 | -15.5% | 216,897 | -2.9% | 0.09% | -10.8% |
| Q2 2021 | $20,827,000 | -12.6% | 223,277 | +0.3% | 0.10% | -20.3% |
| Q1 2021 | $23,816,000 | +34.8% | 222,581 | +10.0% | 0.13% | +45.5% |
| Q4 2020 | $17,671,000 | +78.2% | 202,436 | +40.9% | 0.09% | +44.3% |
| Q3 2020 | $9,918,000 | +0.8% | 143,699 | -29.3% | 0.06% | -20.8% |
| Q2 2020 | $9,839,000 | – | 203,123 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |